Conference
Secukinumab shows sustained response in subjects with moderate-to-severe plaque psoriasis: a subanalysis of the ERASURE phase 3 study
Authors
Wylie A; Lebwohl M; Vender R; Menter A; Karpov A; Papavassilis C
Volume
56
Pagination
pp. 83-83
Publisher
WILEY-BLACKWELL
Publication Date
May 1, 2015
Conference proceedings
AUSTRALASIAN JOURNAL OF DERMATOLOGY
ISSN
0004-8380